<?xml version="1.0" encoding="UTF-8"?>
<p>Cao et al.
 <xref rid="CIT0005" ref-type="bibr">
  <sup>5</sup>
 </xref>
 <sup>,</sup>
 <xref rid="CIT0047" ref-type="bibr">
  <sup>47</sup>
 </xref>
 <sup>,</sup>
 <xref rid="CIT0048" ref-type="bibr">
  <sup>48</sup>
 </xref> further isolated the sponges and found two compounds that inhibited FTase, xestosaprol C methylacetal (
 <bold>11</bold>), and orhalquinone (
 <bold>12</bold>). Compound 
 <bold>11</bold> possess significant inhibitory activity against human FTase in µM range (IC
 <sub>50</sub> = 4.34 µM). Compound 
 <bold>12</bold> showed inhibitory activity against human and yeast FTase (IC
 <sub>50</sub> = 0.40 μM), with a stronger inhibitory effect than xestosaprol C methylacetal. At the same time, Orhalquinone is a moderate growth inhibitor of 
 <italic>P. falciparum</italic>
 <xref rid="CIT0048" ref-type="bibr">
  <sup>48</sup>
 </xref>. Besides, Cao et al.
 <xref rid="CIT0005" ref-type="bibr">
  <sup>5</sup>
 </xref> also found that 3-ketoadociaquinone A (
 <bold>13</bold>) and 3-ketoadociaquinone B (
 <bold>14</bold>) have inhibitory effects on FTase (IC
 <sub>50</sub> = 4.19 and 9.27 µM) and GGTase (IC
 <sub>50</sub> = 1.08 and 3.89 µM).
</p>
